Melbourne drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has signed a licensing agreement with Intas Pharmaceuticals Ltd, an India based pharmaceuticals company, for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Intas Pharmaceuticals’ new warning letter from the U.S. FDA reads like a checklist of what not to do when the regulator pays a visit to your manufacturing facility. The FDA handed Intas a ...

PISCATAWAY, N.J., February 09, 2026--(BUSINESS WIRE)--Kashiv BioSciences, LLC ("Kashiv") a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive ...

Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera’s innovative proprietary SQore™ formulation platform. Intas will ...

Get all latest & breaking news on Intas Pharmaceuticals. Watch videos, top stories and articles on Intas Pharmaceuticals at moneycontrol.com.

Get all latest & breaking news on Intas Pharma. Watch videos, top stories and articles on Intas Pharma at moneycontrol.com.

AHMEDABAD, India, Oct. 12, 2021 /PRNewswire/ -- One of the world's leading pharmaceutical companies, Intas Pharmaceuticals, has made a progressive breakthrough in the Antifungal Therapy domain with ...

AHMEDABAD, India, July 22, 2021 /CNW/ -- Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreement ...

This collaboration deepens the strategic partnership between the two companies and opens new development opportunities for serplulimab's global layout. Under the terms of the agreement, Henlius will ...

Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative condition of the eyes in the elderly Intas Pharmaceuticals has launched ...

MUMBAI (Reuters) - Intas Pharmaceuticals Ltd could get approval this year to launch a version of Amgen Inc's (AMGN.O) white blood cell boosting Neulasta drug in the United States, chief financial ...